Controlled trials show no clear benefit of inhaled opioids over oral or i.v. administration in the treatment of dyspnea. Low-dose oral or sublingual opioids are effective in treating dyspnea.

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

There is no evidence of medication-related toxic effects or intracranial or intraocular disease. None of the common causes of nausea would explain the dyspnea or palpitations except as mediated ...

The following is a summary of “Investigation of the Relationship Between the Measured Alpha Angle in Capnography and Readmission Within Thirty Days in Chronic Obstructive Pulmonary Disease Patients ...

It was added to cold and flu remedies in the 1990s when another ingredient went behind the counter over illicit meth lab concerns.